Abstract
Learning Point for Clinicians 1. Blood product transfusion and point-of-care tests can be safely and successfully used in Ebola virus disease (EVD) in resource-constrained settings. 2. Significant coagulopathy and haemorrhage in EVD is not always a pre-terminal event and patients can survive with advanced supportive care. A 28-year-old nurse presented to the Kerry Town Ebola Virus Disease Treatment Unit (EVDTU) in Sierra Leone on Day 5 of his illness with a positive Ebola Virus reverse transcriptase polymerase chain reaction (RT-PCR) test result, made on Day 3 at his employing hospital. His presenting symptoms included malaise, headache, sore throat, nausea and diarrhoea. Initial examination findings demonstrated a fever of 39°C and mild epigastric tenderness but was otherwise unremarkable. A rapid malaria test was negative. Although the EVDTU has a …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: QJM : monthly journal of the Association of Physicians
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
